THE EFFECTS OF OLMESARTAN/AMLODIPINE ON METABOLIC AND INFLAMMATION MEDIATORS IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME ARE DOSE-DEPENDENT: THE OLAS STUDY

被引：0
|
作者：
Martinez Martin, F. [1 ]
机构：
[1] Hosp Dr Negrin, Endocrinol Dpt, Las Palmas Gran Canaria, Spain
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
10.1097/01.hjh.0000378523.81991.01
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E107 / E108
页数：3
相关论文
共 50 条
  • [21] VASOPROTECTIVE EFFICACY OF THE COMBINED THERAPY WITH AMLODIPINE AND MOXONIDINE IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME
    Shakirova, N. Sh.
    Zakirova, F. A.
    Srojidinova, N. Z.
    Eliseyeva, M. R.
    JOURNAL OF HYPERTENSION, 2009, 27 : S88 - S88
  • [22] Effects of an amlodipine- and olmesartan medoxomil-based titration regimen in patients with hypertension, type 2 diabetes and metabolic syndrome
    Ram, C. Venkata S.
    Sachson, Richard A.
    Qian, Chunlin
    Stoakes, Kathy A.
    Chavanu, Kathleen J.
    PHARMACOTHERAPY, 2013, 33 (10): : E187 - E188
  • [23] Endothelial and metabolic effects of indapamide retard and hydrochlorothiazide in hypertensive patients with metabolic syndrome
    Zhivilova, L. A.
    Semyonkin, A. A.
    Nazarov, A. G.
    Protskyi, I. A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 178 - 178
  • [24] Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome
    Zanoli, L.
    Di Pino, A.
    Terranova, V
    Di Marca, S.
    Pisano, M.
    Di Quattro, R.
    Ferrara, V
    Scicali, R.
    Rabuazzo, A. M.
    Fatuzzo, R.
    Castellino, R.
    Piro, S.
    Purrello, F.
    Malatino, L.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (12) : 1222 - 1229
  • [25] INFLAMMATION AND VENTRICULAR-VASCULAR COUPLING IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME
    Zanoli, L.
    Di Pino, A.
    Terranova, V.
    Di Marca, S.
    Pisano, M.
    Di Quattro, R.
    Ferrara, V.
    Scicali, R.
    Rabuazzo, A.
    Fatuzzo, P.
    Castellino, P.
    Piro, S.
    Purrello, F.
    Malatino, L.
    JOURNAL OF HYPERTENSION, 2019, 37 : E139 - E139
  • [26] Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome
    Ooi, Esther M. M.
    Watts, Gerald F.
    Nestel, Paul J.
    Sviriclov, Dmitri
    Hoang, Anh
    Barrett, P. Hugh R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (02): : 430 - 437
  • [27] Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome
    Ooi, Esther M. M.
    Barrett, P. Hugh R.
    Chan, Dick C.
    Watts, Gerald F.
    Watts, Gerald F.
    ATHEROSCLEROSIS, 2008, 197 (01) : 139 - 146
  • [28] Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome
    Ooi, E. M. M.
    Barrett, P. H. R.
    Chan, D. C.
    Nestel, P. J.
    Watts, G. F.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 225 - 226
  • [29] Dose-dependent effect of rosuvastatin on high-density lipoprotein kinetics in the metabolic syndrome
    Ooi, Esther M.
    Watts, Gerald F.
    Nestel, Paul J.
    Sviridov, Dmitri
    Barrett, Hugh R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 386A - 386A
  • [30] Dose-dependent improvement in high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome
    Ooi, E. M. M.
    Watts, G. F.
    Nestel, P. J.
    Sviridov, D.
    Hoang, A.
    Barrett, P. H. R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 225 - 225
12345